Atossa Genetics Research and Development Expenses 2012-2025 | ATOS
Atossa Genetics research and development expenses from 2012 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
| Atossa Genetics Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | $14 |
| 2023 | $17 |
| 2022 | $15 |
| 2021 | $9 |
| 2020 | $7 |
| 2019 | $7 |
| 2018 | $4 |
| 2017 | $2 |
| 2016 | $1 |
| 2015 | $2 |
| 2014 | $1 |
| 2013 | $1 |
| 2012 | $2 |
| 2011 | $0 |
| Atossa Genetics Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $4 |
| 2024-12-31 | $3 |
| 2024-09-30 | $3 |
| 2024-06-30 | $4 |
| 2024-03-31 | $4 |
| 2023-12-31 | $6 |
| 2023-09-30 | $4 |
| 2023-06-30 | $4 |
| 2023-03-31 | $4 |
| 2022-12-31 | $5 |
| 2022-09-30 | $5 |
| 2022-06-30 | $3 |
| 2022-03-31 | $1 |
| 2021-12-31 | $2 |
| 2021-09-30 | $2 |
| 2021-06-30 | $4 |
| 2021-03-31 | $1 |
| 2020-12-31 | $2 |
| 2020-09-30 | $2 |
| 2020-06-30 | $2 |
| 2020-03-31 | $1 |
| 2019-12-31 | $1 |
| 2019-09-30 | $2 |
| 2019-06-30 | $3 |
| 2019-03-31 | $1 |
| 2018-12-31 | $1 |
| 2018-09-30 | $1 |
| 2018-06-30 | $1 |
| 2018-03-31 | $0 |
| 2017-12-31 | $0 |
| 2017-09-30 | $1 |
| 2017-06-30 | $1 |
| 2017-03-31 | $1 |
| 2016-12-31 | $0 |
| 2016-09-30 | $0 |
| 2016-06-30 | $0 |
| 2016-03-31 | $0 |
| 2015-12-31 | $0 |
| 2015-09-30 | $1 |
| 2015-06-30 | $0 |
| 2015-03-31 | $1 |
| 2014-12-31 | $-1 |
| 2014-09-30 | $1 |
| 2014-06-30 | $1 |
| 2014-03-31 | $0 |
| 2013-12-31 | $0 |
| 2013-09-30 | $0 |
| 2013-06-30 | $0 |
| 2013-03-31 | $0 |
| 2012-12-31 | $0 |
| 2012-09-30 | $1 |
| 2012-06-30 | $1 |
| 2012-03-31 | $0 |
| 2011-12-31 | |
| 2011-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.106B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $192.825B | 84.46 |
| Thermo Fisher Scientific (TMO) | United States | $159.102B | 19.25 |
| Edwards Lifesciences (EW) | United States | $45.274B | 29.68 |
| Alcon (ALC) | Switzerland | $43.909B | 29.67 |
| IDEXX Laboratories (IDXX) | United States | $43.641B | 50.15 |
| DexCom (DXCM) | United States | $32.772B | 50.65 |
| IQVIA Holdings (IQV) | United States | $28.132B | 15.76 |
| Mettler-Toledo (MTD) | United States | $25.049B | 29.79 |
| STERIS (STE) | Ireland | $23.871B | 26.29 |
| Waters (WAT) | United States | $21.247B | 29.98 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.939B | 0.00 |
| Hologic (HOLX) | United States | $14.558B | 15.82 |
| Sysmex ADR (SSMXY) | Japan | $10.852B | 30.79 |
| Penumbra (PEN) | United States | $9.708B | 76.19 |
| Masimo (MASI) | United States | $9.164B | 33.80 |
| Globus Medical (GMED) | United States | $8.150B | 19.42 |
| Glaukos (GKOS) | United States | $5.858B | 0.00 |
| Teleflex (TFX) | United States | $5.384B | 8.89 |
| TransMedics (TMDX) | United States | $4.401B | 95.66 |
| Integer Holdings (ITGR) | United States | $4.232B | 22.17 |
| PROCEPT BioRobotics (PRCT) | United States | $3.130B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.495B | 14.85 |
| Nihon Kohden (NHNKY) | Japan | $2.305B | 26.43 |
| Veracyte (VCYT) | United States | $2.140B | 30.02 |
| Elekta AB (EKTAY) | Sweden | $1.918B | 17.24 |
| Alphatec Holdings (ATEC) | United States | $1.598B | 0.00 |
| Artivion (AORT) | United States | $1.313B | 123.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.148B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.030B | 5.48 |
| Pulse Biosciences (PLSE) | United States | $0.998B | 0.00 |
| SiBone (SIBN) | United States | $0.780B | 0.00 |
| IRadimed (IRMD) | United States | $0.769B | 39.04 |
| Beta Bionics (BBNX) | United States | $0.604B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.579B | 9.01 |
| RxSight (RXST) | United States | $0.533B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.533B | 12.49 |
| OrthoPediatrics (KIDS) | United States | $0.531B | 0.00 |
| AxoGen (AXGN) | United States | $0.499B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.444B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.438B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.395B | 10.51 |
| Pacific Biosciences Of California (PACB) | United States | $0.387B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.387B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.379B | 0.00 |
| NeuroPace (NPCE) | United States | $0.344B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.315B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.265B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.238B | 14.41 |
| 908 Devices (MASS) | United States | $0.232B | 0.00 |
| Neuronetics (STIM) | United States | $0.228B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.227B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.210B | 0.00 |
| Inogen (INGN) | United States | $0.191B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.172B | 0.00 |
| CVRx (CVRX) | United States | $0.157B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.153B | 0.00 |
| LENSAR (LNSR) | United States | $0.151B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.134B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.119B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 46.40 |
| EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
| Spectral AI (MDAI) | United States | $0.068B | 0.00 |
| InspireMD (NSPR) | United States | $0.068B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.062B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.025B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.44 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |